Key result
Transcatheter balloon dilatation of the aortic valve acutely reduced the median catheter pullback gradient from 55 to 30 mm Hg (p < 0.01), though 10 of 22 patients required further intervention.
Why the study?
Does transcatheter balloon dilatation of the aortic valve improve hemodynamics in patients with restenosis after previous surgical valvotomy?
Cohort (n=22)
No
Does transcatheter balloon dilatation of the aortic valve improve hemodynamics in patients with restenosis after previous surgical valvotomy?
Balloon dilatation of the aortic valve is a safe and feasible palliative option for restenosis after surgical valvotomy, though many patients eventually require further intervention.
May support palliative use in post-valvotomy restenosis; leaves open durability versus reoperation.
OBJECTIVE: To evaluate the immediate and long-term results of transcatheter balloon dilatation of the aortic valve for restenosis after previous surgical valvotomy. DESIGN: Prospective follow up by clinical examination and cross sectional Doppler echocardiography of all patients fulfilling the above criteria. SETTING: Tertiary paediatric cardiology referral centre. PATIENTS AND METHODS: 22 patients (18 male, 4 female)--median (range) age 157.5 (12-254) months--underwent 25 balloon dilatation procedures at a median of 72 (8-155) months after surgery. The median age at surgical valvotomy was 82.5 (0.5-230) months and the systolic gradient across the aortic valve immediately after surgery was 31 (0-49) mm Hg. The indication for dilatation was a Doppler derived peak instantaneous gradient of > 60 mm Hg with grade 2 or less aortic regurgitation. A single balloon was used, and the median balloon to annulus ratio was 1 (0.9-1). RESULTS: After dilatation the catheter pullback gradient decreased acutely from 55 (35-75) to 30 (0-75) mm Hg (p < 0.01) and the Doppler gradient from 74 (52-92) to 40.5 (30-96) mm Hg (p < 0.01). In three patients who underwent a second dilatation of the aortic valve eight months after the first procedure, the pullback gradient decreased from 50 (50-60) to 15 (15-16) mm Hg. Aortic regurgitation grade increased from 1 (0-2) to 2 (1-3); only one patient had grade 3 regurgitation. Over a median follow up of 33 (2-67) months seven patients had aortic valve replacement for recurrent stenosis (six patients) or severe regurgitation (one patient with grade 3 regurgitation after dilatation, who had partial detachment of one of the valve leaflets). There was no significant difference for the pullback gradient (median of 19 v 32.5 mm Hg), Doppler gradient 24 hours after dilatation (33.5 v 50.5 mm Hg; p = 0.03), or the duration of follow up (27.5 v 18 months) between the 12 patients who did not require further dilatation or surgery and the 10 patients who did. CONCLUSIONS: Balloon dilatation of the aortic valve is a safe and feasible option for palliation of restenosis after surgical valvotomy for congenital aortic valve stenosis. In many patients, however, stenosis progressed and a further intervention was required.
No takes yet. Share an insight, caveat, or question.
Sreeram et al. (1994) conducted a cohort in Restenosis after previous surgical valvotomy for congenital aortic valve stenosis (n=22). Transcatheter balloon dilatation of the aortic valve was evaluated on Catheter pullback gradient and Doppler gradient (p=< 0.01). Transcatheter balloon dilatation of the aortic valve acutely reduced the median catheter pullback gradient from 55 to 30 mm Hg (p < 0.01), though 10 of 22 patients required further intervention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: